| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total non-operating income, net | 4,525 | 4,652 | 5,071 | 6,519 |
| Loss before income taxes | 19,726 | 30,322 | 35,996 | -36,155 |
| Income tax expense | 0 | 0 | - | -882 |
| Net loss | -19,726 | -30,322 | -35,996 | 37,037 |
| Earnings per share, basic | -0.19 | -0.29 | -0.35 | 0.38 |
| Earnings per share, diluted | -0.19 | -0.29 | -0.35 | 0.38 |
| Weighted average number of shares outstanding, basic | 103,381,315 | 103,069,154 | 102,710,382 | 96,623,123 |
| Weighted average number of shares outstanding, diluted | 103,381,315 | 103,069,154 | 102,710,382 | 96,937,759 |
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)